A. Sallmann

Active 1978–2014

Affiliations
Novartis (Switzerland)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
6
Papers
1,029
Citations
6
h-index
6
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for A. Sallmann1978: 2 citations1979: 6 citations1980: 3 citations1982: 1 citations1983: 3 citations1984: 1 citations1985: 3 citations1986: 4 citations1987: 1 citations1988: 8 citations1990: 1 citations1991: 4 citations1992: 1 citations1993: 3 citations1994: 1 citations1995: 4 citations1997: 10 citations1998: 5 citations1999: 7 citations2000: 3 citations2001: 5 citations2002: 4 citations2003: 7 citations2004: 8 citations2005: 8 citations2006: 3 citations2007: 4 citations2008: 2 citations2009: 7 citations2010: 4 citations2011: 3 citations2012: 5 citations2013: 1 citations2014: 5 citations2015: 10 citations2016: 6 citations2017: 3 citations2018: 4 citations2019: 13 citations2020: 11 citations2021: 13 citations2022: 9 citations2023: 8 citations2024: 10 citations2025: 1 citations1981: no citations, so this year is not shown1989: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Medicine45%
  • Biochemistry, Genetics and Molecular Biology23.6%
  • Pharmacology, Toxicology and Pharmaceutics16.2%
  • Chemistry4.2%
  • Environmental Science4.2%
  • Computer Science2.6%
  • Other4.2%

Topics

  • Inflammatory mediators and NSAID effects20.8%
  • Breast Cancer Treatment Studies13%
  • Pharmacogenetics and Drug Metabolism11.2%
  • Drug Transport and Resistance Mechanisms6.7%
  • HER2/EGFR in Cancer Research6.7%
  • Cancer Treatment and Pharmacology5.2%
  • Other36.4%

Frequent coauthors

All papers

Loading papers…